HomeTrialNCT07044271
🔬NCT07044271Phase 1RECRUITING

A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants

Study Summary

The main purpose of this study is to measure how much olomorasib gets into the bloodstream and how long it takes the body to get rid of it. Healthy participants will take olomorasib by mouth. The study will last about 7 weeks and will include 10 back-to-back overnight stays in the research center.

Conditions
Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment120 participants
Primary Completion
Lead SponsorEli Lilly and Company
Data Retrieved2026-04-11 02:55:33.866822+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.